These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33806890)

  • 1. Determinants of Population-Based Cancer Screening Performance at Primary Healthcare Institutions in China.
    Zheng S; Zhang X; Greuter MJW; de Bock GH; Lu W
    Int J Environ Res Public Health; 2021 Mar; 18(6):. PubMed ID: 33806890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Willingness of healthcare providers to perform population-based cancer screening: a cross-sectional study in primary healthcare institutions in Tianjin, China.
    Zheng S; Zhang X; Greuter MJW; de Bock GH; Lu W
    BMJ Open; 2024 Apr; 14(4):e075604. PubMed ID: 38569674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined patterns of participation in cervical, breast, and colorectal cancer screenings and factors for non-participation in each screening among women in Japan.
    Ishii K; Tabuchi T; Iso H
    Prev Med; 2021 Sep; 150():106627. PubMed ID: 34019930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
    Bertaut A; Coudert J; Bengrine L; Dancourt V; Binquet C; Douvier S
    PLoS One; 2018; 13(6):e0198939. PubMed ID: 29927995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes.
    Giorgi Rossi P; Carrozzi G; Federici A; Mancuso P; Sampaolo L; Zappa M
    J Med Screen; 2018 Mar; 25(1):17-23. PubMed ID: 28614991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Socioeconomic and healthcare use-related determinants of cervical, breast and colorectal cancer screening practice in the French West Indies.
    Menvielle G; Dugas J; Richard JB; Luce D
    Eur J Cancer Prev; 2018 May; 27(3):269-273. PubMed ID: 27824663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer screening utilization by residence and sexual orientation.
    Lee M; Jenkins WD; Adjei Boakye E
    Cancer Causes Control; 2020 Oct; 31(10):951-964. PubMed ID: 32833199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to national guidelines for colorectal, breast, and cervical cancer screenings in Japanese workplaces: a survey-based classification of enterprises' practices into "overscreening," "underscreening," and "guideline-adherence screening".
    Minamitani M; Tatemichi M; Mukai T; Katano A; Ohira S; Nakagawa K
    BMC Public Health; 2024 Aug; 24(1):2223. PubMed ID: 39148101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer screening participation in schizophrenic outpatients and the influence of their functional disability on the screening rate: A cross-sectional study in Japan.
    Fujiwara M; Inagaki M; Nakaya N; Fujimori M; Higuchi Y; Hayashibara C; So R; Kakeda K; Kodama M; Uchitomi Y; Yamada N
    Psychiatry Clin Neurosci; 2017 Dec; 71(12):813-825. PubMed ID: 28875514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the coverage of cervical and breast cancer screening among women aged 35-69 years and related impact of socioeconomic factors in China, 2013].
    Bao HL; Wang LH; Wang LM; Fang LW; Zhang M; Zhao ZP; Cong S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Feb; 39(2):208-212. PubMed ID: 29495207
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors promoting breast, cervical and colorectal cancer screenings participation: A systematic review.
    Vallone F; Lemmo D; Martino ML; Donizzetti AR; Freda MF; Palumbo F; Lorenzo E; D'Argenzio A; Caso D
    Psychooncology; 2022 Sep; 31(9):1435-1447. PubMed ID: 35793430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for non-participation or partial participation in breast, cervical and colorectal cancer screening programmes†.
    Dawidowicz S; Le Breton J; Moscova L; Renard V; Bercier S; Brixi Z; Audureau E; Clerc P; Bastuji-Garin S; Ferrat E
    Fam Pract; 2020 Feb; 37(1):15-24. PubMed ID: 31305884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium.
    Barlow WE; Beaber EF; Geller BM; Kamineni A; Zheng Y; Haas JS; Chao CR; Rutter CM; Zauber AG; Sprague BL; Halm EA; Weaver DL; Chubak J; Doria-Rose VP; Kobrin S; Onega T; Quinn VP; Schapira MM; Tosteson ANA; Corley DA; Skinner CS; Schnall MD; Armstrong K; Wheeler CM; Silverberg MJ; Balasubramanian BA; Doubeni CA; McLerran D; Tiro JA
    J Natl Cancer Inst; 2020 Mar; 112(3):238-246. PubMed ID: 31292633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge, attitudes and behaviors of breast and cervical cancers and screenings of women working in primary health care services.
    Deniz S; Coskun F; Oztas D; Kurt AO
    J BUON; 2018 Dec; 23(7):44-52. PubMed ID: 30722111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. County-Level Social Vulnerability and Breast, Cervical, and Colorectal Cancer Screening Rates in the US, 2018.
    Bauer C; Zhang K; Xiao Q; Lu J; Hong YR; Suk R
    JAMA Netw Open; 2022 Sep; 5(9):e2233429. PubMed ID: 36166230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast, Cervical, and Colorectal Cancer Screening: Patterns Among Women With Medicaid and Commercial Insurance.
    Bonafede MM; Miller JD; Pohlman SK; Troeger KA; Sprague BL; Herschorn SD; Winer IH
    Am J Prev Med; 2019 Sep; 57(3):394-402. PubMed ID: 31377088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Screening Test Use-U.S., 2019.
    Sabatino SA; Thompson TD; White MC; Shapiro JA; Clarke TC; Croswell JM; Richardson LC
    Am J Prev Med; 2022 Sep; 63(3):431-439. PubMed ID: 35469700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
    Tosteson AN; Beaber EF; Tiro J; Kim J; McCarthy AM; Quinn VP; Doria-Rose VP; Wheeler CM; Barlow WE; Bronson M; Garcia M; Corley DA; Haas JS; Halm EA; Kamineni A; Rutter CM; Tosteson TD; Trentham-Dietz A; Weaver DL;
    J Gen Intern Med; 2016 Apr; 31(4):372-9. PubMed ID: 26658934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening Beyond the Evidence: Patterns of Age and Comorbidity for Breast, Cervical, and Colorectal Cancer Screening.
    Onega T; Garcia M; Beaber EF; Haas JS; Breslau ES; Tosteson ANA; Halm E; Chao CR; Barlow WE
    J Gen Intern Med; 2024 Jun; 39(8):1324-1331. PubMed ID: 38097863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to increase uptake in oncologic screening: a systematic review of studies comparing population-based screening programs and spontaneous access.
    Ferroni E; Camilloni L; Jimenez B; Furnari G; Borgia P; Guasticchi G; Giorgi Rossi P;
    Prev Med; 2012 Dec; 55(6):587-96. PubMed ID: 23064024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.